14 of 21 endometrioid carcinomas (∼66%) tested positive by immunohistochemistry, with SAS1B protein localized to the compartment of the adenocarcinomatous glands (Figure 2E 3–9). The gene discussed is ASTL; the disease is endometrioid adenocarcinoma.